Your Article Summary
Panenza and Humenza Influenza A(H1N1) Vaccines Demonstrate Robust Immune Response After One Dose
Sanofi-aventis, 10/09/09
Sanofi Pasteur, the vaccines division of the sanofi–aventis Group, announced that a single dose of influenza A (H1N1) 2009 monovalent vaccines, Panenza or Humenza, administered to children and adults induces a robust immune response, according to results from clinical trials conducted in Europe.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Article Search
Sponsor


See Latest Articles


